NCT01137643View on ClinicalTrials.gov

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RecruitingOBSERVATIONAL
Enrollment

15,000

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2040

Study Completion Date

July 31, 2040

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsNonmalignant Neoplasm
Interventions
OTHER

biologic sample preservation procedure

All samples collected during routine clinical care.

OTHER

cytology specimen collection procedure

All Samples collected during routine clinical care.

Trial Locations (1)

27599-7295

RECRUITING

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT01137643 - Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter